Trebananib Active Not Recruiting Phase 2 Trials for Stage IV Renal Cell Cancer / Stage IV Renal Cell Cancer AJCC V7 / Renal Cell Carcinoma Recurrent / Stage III Renal Cell Cancer AJCC v7 / Stage III Renal Cell Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01664182Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer